Education

Medical School

University of the Witwatersrand
1969 Johannesburg South Africa

Internship

Medicine Johannesburg Hospital
1970 Johannesburg South Africa

Residency

Pediatrics Transvaal Memorial Hospital for Children
1975 Johannesburg South Africa

Fellowship

University of Chicago Hospitals
1976 Chicago IL

Fellowship

Tufts-New England Medical Center
1978 Boston MA

Publications

  1. Sociodemographic inequities and use of hybrid closed-loop systems associated with obesity in youth with type 1 diabetes. Diabetes Res Clin Pract. 2025 Mar; 221:112041. View Abstract
  2. An auto-ethnographic study of co-produced health research in a patient organisation: unpacking the good, the bad, and the unspoken. Res Involv Engagem. 2024 Jul 23; 10(1):76. View Abstract
  3. Idiopathic Pathological Ketotic Hypoglycemia: Finding the Needle in a Haystack. Horm Res Paediatr. 2024 Mar 21; 1-12. View Abstract
  4. Increased Use of Hyperosmolar Therapy for Suspected Clinically Apparent Brain Injury in Pediatric Patients with Diabetic Ketoacidosis during the Peak of the COVID-19 Pandemic. Pediatr Diabetes. 2023; 2023. View Abstract
  5. Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2023 02 15; 108(3):529-562. View Abstract
  6. ISPAD Clinical Practice Consensus Guidelines 2022: Editorial. Pediatr Diabetes. 2022 Dec; 23(8):1157-1159. View Abstract
  7. Ten-Year Experience of a Global and Freely Accessible e-Learning Website for Pediatric Endocrinology and Diabetes. Horm Res Paediatr. 2023; 96(4):366-375. View Abstract
  8. ISPAD clinical practice consensus guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022 11; 23(7):835-856. View Abstract
  9. Utility of plasma beta-hydroxybutyrate to define resolution of diabetic ketoacidosis. Pediatr Diabetes. 2022 12; 23(8):1621-1627. View Abstract
  10. Monitoring of paediatric type 1 diabetes. Curr Opin Pediatr. 2022 08 01; 34(4):391-399. View Abstract
  11. Plasma ß-Hydroxybutyrate for the Diagnosis of Diabetic Ketoacidosis in the Emergency Department. Pediatr Emerg Care. 2021 Dec 01; 37(12):e1345-e1350. View Abstract
  12. Acquired growth hormone deficiency in Fanconi-Bickel syndrome. BMJ Case Rep. 2021 Nov 02; 14(11). View Abstract
  13. Transforming Education through a Global e-Learning Model for Pediatric Diabetes and Endocrinology. Horm Res Paediatr. 2021; 94(5-6):235-238. View Abstract
  14. A global e-learning initiative for pediatric diabetes and endocrinology: Introduction and description. Pediatr Diabetes. 2021 06; 22(4):692-694. View Abstract
  15. Post-Transplantation Diabetes Mellitus in Pediatric Patients. Horm Res Paediatr. 2020; 93(9-10):510-518. View Abstract
  16. Precocious sexual development in a male toddler caused by unrecognized transdermal exposure to testosterone: case report and review of the literature. J Pediatr Endocrinol Metab. 2021 May 26; 34(5):675-678. View Abstract
  17. Carbohydrate restriction for diabetes: rediscovering centuries-old wisdom. J Clin Invest. 2021 01 04; 131(1). View Abstract
  18. Brain injury in children with diabetic ketoacidosis: Review of the literature and a proposed pathophysiologic pathway for the development of cerebral edema. Pediatr Diabetes. 2021 03; 22(2):148-160. View Abstract
  19. Efficacy of GLP-1 Agonist Therapy in Autosomal Dominant WFS1-Related Disorder: A Case Report. Horm Res Paediatr. 2020; 93(6):409-414. View Abstract
  20. ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID-19 and resource-limited settings-role of subcutaneous insulin. Pediatr Diabetes. 2020 12; 21(8):1394-1402. View Abstract
  21. Improving pediatric endocrinology trainees' knowledge about insulin pumps and continuous glucose monitors with online spaced education: Technology Knowledge Optimization in T1D (TeKnO T1D). Pediatr Diabetes. 2020 08; 21(5):814-823. View Abstract
  22. Perioperative Management of Pediatric Patients With Type 1 Diabetes Mellitus, Updated Recommendations for Anesthesiologists. Anesth Analg. 2020 04; 130(4):821-827. View Abstract
  23. Monitoring of Pediatric Type 1 Diabetes. Front Endocrinol (Lausanne). 2020; 11:128. View Abstract
  24. International Society for Pediatric and Adolescent Diabetes in India: Reaching the unreached. Pediatr Diabetes. 2019 09; 20(6):665-667. View Abstract
  25. SGLT Inhibitors for Type 1 Diabetes: Proceed With Extreme Caution. Diabetes Care. 2019 Jun; 42(6):991-993. View Abstract
  26. Incorporating dextrose gel and feeding in the treatment of neonatal hypoglycaemia. Arch Dis Child Fetal Neonatal Ed. 2020 Jan; 105(1):45-49. View Abstract
  27. Glycogen storage disease presenting as Cushing syndrome. JIMD Rep. 2019 May; 47(1):17-22. View Abstract
  28. Neither fluid rate nor sodium content affect neurocognitive outcomes in DKA. J Pediatr. 2019 03; 206:298-301. View Abstract
  29. Hypoglycemia in the Newborn. Pediatr Clin North Am. 2019 04; 66(2):333-342. View Abstract
  30. Pediatric Endocrinology Trainees' Education and Knowledge About Insulin Pumps and Continuous Glucose Monitors. Diabetes Technol Ther. 2019 03; 21(3):105-109. View Abstract
  31. ISPAD Position Statement on Type 1 Diabetes in Schools. Pediatr Diabetes. 2018 11; 19(7):1338-1341. View Abstract
  32. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018 10; 19 Suppl 27:155-177. View Abstract
  33. Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association. Diabetes Care. 2018 09; 41(9):2026-2044. View Abstract
  34. Resolution of ketoacidosis in children with new onset diabetes: Evaluation of various definitions. Diabetes Res Clin Pract. 2018 Jan; 135:76-84. View Abstract
  35. Characteristics of youth with type 1 diabetes (T1D) with and without a parent with T1D in the T1D exchange clinic registry. J Diabetes. 2016 Nov; 8(6):834-838. View Abstract
  36. Utility of diabetes-associated autoantibodies for classification of new onset diabetes in children and adolescents. Pediatr Diabetes. 2016 09; 17(6):417-25. View Abstract
  37. Use of Serum Bicarbonate to Substitute for Venous pH in New-Onset Diabetes. Pediatrics. 2015 Aug; 136(2):e371-7. View Abstract
  38. The Impact of Technology on Current Diabetes Management. Pediatr Clin North Am. 2015 Aug; 62(4):873-88. View Abstract
  39. Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children. J Pediatr. 2015 Aug; 167(2):238-45. View Abstract
  40. Re-evaluating "transitional neonatal hypoglycemia": mechanism and implications for management. J Pediatr. 2015 Jun; 166(6):1520-5.e1. View Abstract
  41. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014 Nov; 16(11):e1. View Abstract
  42. ISPAD Clinical Practice Consensus Guidelines 2014. The delivery of ambulatory diabetes care to children and adolescents with diabetes. Pediatr Diabetes. 2014 Sep; 15 Suppl 20:86-101. View Abstract
  43. ISPAD Clinical Practice Consensus Guidelines 2014. Management of children and adolescents with diabetes requiring surgery. Pediatr Diabetes. 2014 Sep; 15 Suppl 20:224-31. View Abstract
  44. ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2014 Sep; 15 Suppl 20:154-79. View Abstract
  45. The International Society of Pediatric and Adolescent Diabetes guidelines for management of diabetic ketoacidosis: Do the guidelines need to be modified? Pediatr Diabetes. 2014 Jun; 15(4):277-86. View Abstract
  46. Routine behavioral and mental health screening in young children with type 1 diabetes mellitus. Pediatr Diabetes. 2014 Aug; 15(5):384-8. View Abstract
  47. Health care transition in young adults with type 1 diabetes: barriers to timely establishment of adult diabetes care. Endocr Pract. 2013 Nov-Dec; 19(6):946-52. View Abstract
  48. Transition experiences and health care utilization among young adults with type 1 diabetes. Patient Prefer Adherence. 2013; 7:761-9. View Abstract
  49. Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry. Pediatr Diabetes. 2013 Sep; 14(6):447-54. View Abstract
  50. Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism. J Clin Lipidol. 2012 Nov-Dec; 6(6):596-600. View Abstract
  51. Health care transition in patients with type 1 diabetes: young adult experiences and relationship to glycemic control. Diabetes Care. 2012 Aug; 35(8):1716-22. View Abstract
  52. Utility of immediate hemoglobin A1c in children with type I diabetes mellitus. Pediatr Diabetes. 2010 Nov; 11(7):450-4. View Abstract
  53. Contemporary management of patients with type 1 diabetes. Endocrinol Metab Clin North Am. 2010 Sep; 39(3):573-93. View Abstract
  54. Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy. J Autoimmun. 2010 Jun; 34(4):408-15. View Abstract
  55. Pediatrics: HbA1c levels for the diagnosis of diabetes mellitus in children. Nat Rev Endocrinol. 2010 Jun; 6(6):304-5. View Abstract
  56. Research initiatives in neonatal hypoglycemia. J Pediatr. 2010 May; 156(5):862-3; author reply 863. View Abstract
  57. The delivery of ambulatory diabetes care to children and adolescents with diabetes. Pediatr Diabetes. 2009 Sep; 10 Suppl 12:58-70. View Abstract
  58. Diabetic ketoacidosis in children and adolescents with diabetes. Pediatr Diabetes. 2009 Sep; 10 Suppl 12:118-33. View Abstract
  59. Management of children and adolescents with diabetes requiring surgery. Pediatr Diabetes. 2009 Sep; 10 Suppl 12:169-74. View Abstract
  60. How effective is continuous glucose monitoring in intensively treated type 1 diabetes mellitus? Nat Clin Pract Endocrinol Metab. 2009 Mar; 5(3):134-5. View Abstract
  61. The delivery of ambulatory diabetes care: structures, processes, and outcomes of ambulatory diabetes care. Pediatr Diabetes. 2008 Dec; 9(6):609-20. View Abstract
  62. The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results. Pediatr Diabetes. 2009 Apr; 10(2):97-104. View Abstract
  63. Can biochemical markers discriminate between new-onset type 1 and type 2 diabetes mellitus in children? Nat Clin Pract Endocrinol Metab. 2007 Dec; 3(12):800-1. View Abstract
  64. Management of children with diabetes requiring surgery. Pediatr Diabetes. 2007 Aug; 8(4):242-7. View Abstract
  65. Diabetic ketoacidosis. Pediatr Diabetes. 2007 Feb; 8(1):28-43. View Abstract
  66. Hypothyroidism in a breast-fed preterm infant resulting from maternal topical iodine exposure. J Pediatr. 2006 Oct; 149(4):566-7. View Abstract
  67. How effective is biphasic insulin aspart in the treatment of adolescents with type 1 diabetes? Nat Clin Pract Endocrinol Metab. 2006 Sep; 2(9):486-7. View Abstract
  68. Understanding protein-sensitive hypoglycemia. J Pediatr. 2006 Jul; 149(1):6-7. View Abstract
  69. Diabetic ketoacidosis in infants, children, and adolescents: A consensus statement from the American Diabetes Association. Diabetes Care. 2006 May; 29(5):1150-9. View Abstract
  70. Characteristics at diagnosis of type 1 diabetes in children younger than 6 years. J Pediatr. 2006 Mar; 148(3):366-71. View Abstract
  71. Hepatic glycogen synthase deficiency: an infrequently recognized cause of ketotic hypoglycemia. Mol Genet Metab. 2006 Apr; 87(4):284-8. View Abstract
  72. Children with diabetes benefit from exercise. Arch Dis Child. 2005 Dec; 90(12):1215-7. View Abstract
  73. Perioperative management of pediatric surgical patients with diabetes mellitus. Anesth Analg. 2005 Oct; 101(4):986-999. View Abstract
  74. Diabetic ketoacidosis in children. Pediatr Clin North Am. 2005 Aug; 52(4):1147-63, ix. View Abstract
  75. Effect of low-dose insulin treatment on body weight and physical development in children and adolescents at risk for type 1 diabetes. Diabetes Care. 2005 Aug; 28(8):1948-53. View Abstract
  76. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1. Diabetes Care. 2005 May; 28(5):1068-76. View Abstract
  77. Sexual development in a 21 month-old boy caused by testosterone contamination of a topical hydrocortisone cream. J Pediatr Endocrinol Metab. 2005 May; 18(5):507-10. View Abstract
  78. Diabetes mellitus in children and adolescents. Arch Med Res. 2005 May-Jun; 36(3):281-90. View Abstract
  79. Perioperative management of diabetes insipidus in children. J Neurosurg Anesthesiol. 2004 Jul; 16(3):220-5. View Abstract
  80. Oral sucrose and exercise tolerance in McArdle's disease. N Engl J Med. 2004 Apr 08; 350(15):1575-6; author reply 1575-6. View Abstract
  81. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child. 2004 Feb; 89(2):188-94. View Abstract
  82. European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics. 2004 Feb; 113(2):e133-40. View Abstract
  83. Perioperative management of diabetes insipidus in children [corrected]. J Neurosurg Anesthesiol. 2004 Jan; 16(1):14-9. View Abstract
  84. Glycogen storage diseases. Rev Endocr Metab Disord. 2003 Mar; 4(1):95-102. View Abstract
  85. Bones benefit from better biochemical control in type 1 glycogen storage disease. J Pediatr. 2002 Sep; 141(3):308-10. View Abstract
  86. Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease. Eur J Pediatr. 2002 Oct; 161 Suppl 1:S35-9. View Abstract
  87. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood. 2002 Nov 15; 100(10):3776-81. View Abstract
  88. Leptin-replacement therapy in lipodystrophy. N Engl J Med. 2002 Jun 20; 346(25):2008-9; author reply 2009-10. View Abstract
  89. Glycogen synthase deficiency (glycogen storage disease type 0) presenting with hyperglycemia and glucosuria: report of three new mutations. J Pediatr. 2002 Jun; 140(6):781-3. View Abstract
  90. Decreased urinary citrate excretion in type 1a glycogen storage disease. J Pediatr. 2001 Mar; 138(3):378-82. View Abstract
  91. First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. J Pediatr. 2001 Feb; 138(2):244-9. View Abstract
  92. Urinary lactate excretion to monitor the efficacy of treatment of type I glycogen storage disease. Mol Genet Metab. 2000 Jul; 70(3):189-95. View Abstract
  93. Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function. J Crit Care. 2000 Mar; 15(1):1-4. View Abstract
  94. Glycogen storage diseases. Phenotypic, genetic, and biochemical characteristics, and therapy. Endocrinol Metab Clin North Am. 1999 Dec; 28(4):801-23. View Abstract
  95. Improving diabetes control in adolescents. Diabetes Care. 1999 Nov; 22(11):1767-8. View Abstract
  96. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease. J Pediatr Gastroenterol Nutr. 1999 Aug; 29(2):136-43. View Abstract
  97. Hyperinsulinemic hypoglycemia of infancy. J Pediatr. 1998 Jan; 132(1):1-3. View Abstract
  98. Fewer interventions in the immediate post-extubation management of pediatric intensive care unit patients: safety and cost containment. J Crit Care. 1997 Dec; 12(4):173-6. View Abstract
  99. Consequences of irregular versus continuous medical follow-up in children and adolescents with insulin-dependent diabetes mellitus. J Pediatr. 1997 Nov; 131(5):727-33. View Abstract
  100. Metabolic control and renal dysfunction in type I glycogen storage disease. J Inherit Metab Dis. 1997 Aug; 20(4):559-68. View Abstract
  101. Cornstarch regimens for nocturnal treatment of young adults with type I glycogen storage disease. Am J Clin Nutr. 1997 May; 65(5):1507-11. View Abstract
  102. Psychological adjustment to IDDM: 10-year follow-up of an onset cohort of child and adolescent patients. Diabetes Care. 1997 May; 20(5):811-8. View Abstract
  103. Social relationships among young adults with insulin-dependent diabetes mellitus: ten-year follow-up of an onset cohort. Diabet Med. 1997 Jan; 14(1):73-9. View Abstract
  104. Psychosocial predictors of acute complications of diabetes in youth. Diabet Med. 1995 Jul; 12(7):612-8. View Abstract
  105. Family environment and glycemic control: a four-year prospective study of children and adolescents with insulin-dependent diabetes mellitus. Psychosom Med. 1994 Sep-Oct; 56(5):401-9. View Abstract
  106. Diabetes in childhood: predicting the future. Pediatr Ann. 1994 Jun; 23(6):306-12. View Abstract
  107. Glycogen storage disease in adults. Ann Intern Med. 1994 Feb 01; 120(3):218-26. View Abstract
  108. Biochemical evidence for the requirement of continuous glucose therapy in young adults with type 1 glycogen storage disease. J Inherit Metab Dis. 1994; 17(2):234-41. View Abstract
  109. Distinction between transient hyperglycemia and early insulin-dependent diabetes mellitus in childhood: a prospective study of incidence and prognostic factors. J Pediatr. 1993 Sep; 123(3):347-54. View Abstract
  110. Optimal daytime feeding regimen to prevent postprandial hypoglycemia in type 1 glycogen storage disease. Am J Clin Nutr. 1992 Sep; 56(3):587-92. View Abstract
  111. Severe hypoglycemia in youth with insulin-dependent diabetes mellitus: frequency and causative factors. Pediatrics. 1991 Dec; 88(6):1187-93. View Abstract
  112. Split-mixed insulin regimen with human ultralente before supper and NPH (isophane) before breakfast in children and adolescents with IDDM. Diabetes Care. 1991 Nov; 14(11):1100-6. View Abstract
  113. Clinic attendance and glycemic control. Study of contrasting groups of patients with IDDM. Diabetes Care. 1991 Jul; 14(7):599-601. View Abstract
  114. Continuous glucose for treatment of patients with type 1 glycogen-storage disease: comparison of the effects of dextrose and uncooked cornstarch on biochemical variables. Am J Clin Nutr. 1990 Dec; 52(6):1043-50. View Abstract
  115. Physical growth and development of children with type 1 glycogen-storage disease: comparison of the effects of long-term use of dextrose and uncooked cornstarch. Am J Clin Nutr. 1990 Dec; 52(6):1051-7. View Abstract
  116. Glucose therapy for glycogenosis type 1 in infants: comparison of intermittent uncooked cornstarch and continuous overnight glucose feedings. J Pediatr. 1990 Sep; 117(3):384-91. View Abstract
  117. Adherence among children and adolescents with insulin-dependent diabetes mellitus over a four-year longitudinal follow-up: I. The influence of patient coping and adjustment. J Pediatr Psychol. 1990 Aug; 15(4):511-26. View Abstract
  118. Adherence among children and adolescents with insulin-dependent diabetes mellitus over a four-year longitudinal follow-up: II. Immediate and long-term linkages with the family milieu. J Pediatr Psychol. 1990 Aug; 15(4):527-42. View Abstract
  119. Screening for thyroid disease in children with IDDM. Diabetes Care. 1990 Jul; 13(7):801-3. View Abstract
  120. Psychological characteristics of adults with IDDM. Comparison of patients in poor and good glycemic control. Diabetes Care. 1990 Apr; 13(4):375-81. View Abstract
  121. Transient hyperglycemia in childhood: identification of a subgroup with imminent diabetes mellitus. Diabetes Res. 1988 Dec; 9(4):161-7. View Abstract
  122. Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diabetes Care. 1988 Oct; 11(9):736-9. View Abstract
  123. Relationship of nocturnal hypoglycemia to daytime glycemia in IDDM. Diabetes Care. 1988 Sep; 11(8):636-42. View Abstract
  124. How families cope with diabetes in adolescence. An approach and case analyses. Pediatrician. 1988; 15(1-2):80-94. View Abstract
  125. Psychologic predictors of compliance in children with recent onset of diabetes mellitus. J Pediatr. 1987 May; 110(5):805-11. View Abstract
  126. Isolated growth hormone deficiency after cerebral edema complicating diabetic ketoacidosis. N Engl J Med. 1987 Apr 02; 316(14):857-9. View Abstract
  127. Psychological adjustment of children with recently diagnosed diabetes mellitus. Diabetes Care. 1986 Jul-Aug; 9(4):323-9. View Abstract
  128. Children with recently diagnosed diabetes: interactions within their families. Health Psychol. 1986; 5(3):273-96. View Abstract
  129. Subclinical brain swelling in children during treatment of diabetic ketoacidosis. N Engl J Med. 1985 May 02; 312(18):1147-51. View Abstract
  130. Ketonuria does not exclude hyperinsulinemic hypoglycemia. Am J Dis Child. 1984 Feb; 138(2):168-71. View Abstract
  131. Hypoketonemia and age-related fasting hypoglycemia in growth hormone deficiency. Metabolism. 1983 May; 32(5):457-62. View Abstract
  132. Fat-derived fuels during a 24-hour fast in children. Eur J Pediatr. 1982 Mar; 138(2):141-4. View Abstract
  133. Hypoalaninemia and ketotic hypoglycemia: cause or consequence? Eur J Pediatr. 1982 Feb; 138(1):28-31. View Abstract
  134. Hyperprolactinemia causing primary amenorrhea. J Pediatr. 1981 Nov; 99(5):802-4. View Abstract
  135. Hemolytic uremic syndrome associated with Kawasaki disease. Pediatrics. 1981 Sep; 68(3):405-6. View Abstract
  136. Pubertal presentation of congenital delta 5-3 beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1980 Aug; 51(2):345-53. View Abstract
  137. Failure to thrive and metabolic alkalosis. Adverse effects of a chloride-deficient formula in two infants. JAMA. 1980 Mar 14; 243(10):1068-70. View Abstract
  138. Hypoparathyroidism and pregnancy. Treatment with calcitriol. JAMA. 1980 Jan 18; 243(3):254-5. View Abstract
  139. The diagnosis of insulinoma in a child in the absence of fasting hyperinsulinemia. Pediatrics. 1979 Oct; 64(4):496-8. View Abstract
  140. Familial nesidioblastosis: severe neonatal hypoglycemia in two families. J Pediatr. 1979 Jul; 95(1):44-53. View Abstract
  141. Hypoglycemia in children. Pediatr Clin North Am. 1979 Feb; 26(1):171-85. View Abstract
  142. Partial gonadotrophin-resistance in pseudohypoparathyroidism. Acta Endocrinol (Copenh). 1978 Jun; 88(2):321-8. View Abstract
  143. Kerosene absorption in primates. J Pediatr. 1977 Sep; 91(3):495-8. View Abstract
  144. Hepatic enzymes, their induction and usefulness in predicting maximal serum bilirubin levels in premature newborn infants. Eur J Pediatr. 1977 Jun 01; 125(2):97-102. View Abstract
  145. Growth and nutrition of uremic piglets. Pediatr Res. 1976 Nov; 10(11):937-44. View Abstract
  146. Occurrence of primary hepatocellular cancer and peliosis hepatis after treatment with androgenic steroids. S Afr Med J. 1976 Jul 24; 50(32):1233-7. View Abstract
  147. Kerosene intoxication: an experimental approach to the etiology of the CNS manifestations in primates. J Pediatr. 1976 Jun; 88(6):1037-40. View Abstract
  148. Transpyloric feeding in small preterm infants. Arch Dis Child. 1975 Sep; 50(9):723-6. View Abstract
  149. Bicarbonate excretion in kwashiorkor. S Afr Med J. 1975 Aug 09; 49(34):1398-400. View Abstract
  150. Transcutaneous determination of arterial oxygen tension. Pediatrics. 1975 Feb; 55(2):224-31. View Abstract
  151. The influence of body position on pulmonary function in low birthweight babies. S Afr Med J. 1975 Jan 18; 49(3):79-81. View Abstract
  152. The acute care of respiratory problems in the neonate, infant, and child. Int Anesthesiol Clin. 1975; 13(3):73-131. View Abstract
  153. Dexamethasone in the management of kerosene pneumonia. Pediatrics. 1974 Jan; 53(1):86-90. View Abstract
  154. Report by the department of paediatrics on the special care area of the Transvaal Memorial Hospital for Children. S Afr Med J. 1973 Oct 13; 47(40):1851-4. View Abstract
  155. Mist therapy reconsidered; an evaluation of the respiratory deposition of labelled water aerosols produced by jet and ultrasonic nebulizers. Pediatrics. 1969 May; 43(5):799-808. View Abstract
  156. Mist therapy. Pediatrics. 1969 May; 43(5):903-4. View Abstract
  157. Tuberculosis in children. Clin Notes Respir Dis. 1969; 7(4):3-10. View Abstract
  158. Diagnosis and treatment: approaches to newborn infants of tuberculous mothers. Pediatrics. 1968 Sep; 42(3):519-22. View Abstract
  159. Screening tests for growth-hormone deficiency in dwarfism. Lancet. 1967 Dec 16; 2(7529):1271-3. View Abstract

Contact Joseph Wolfsdorf

Print Profile